07:00 , Aug 22, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Obesity Melanocortin 2 receptor accessory protein 2 (MRAP2) Studies in human samples and in mice suggest activating MRAP2 could help...